Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001171843-25-002086

Gen Counsel & Corporate Sec bought 20,000 shares at $1.54 ($30,800)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anderman Jonathan Gen Counsel & Corporate Sec 2025-04-07 Purchase +20,000 $1.54 $30,800 21,000 D
Open-market purchases · 20,000 sh · avg $1.54 · $30,800
Loading xslF345X05/ownership.xml…